Search

Search bills, members, committees and pages...

H.R. 1060

U.S. HouseIn House Committee

Summary

H.R. 1060, the Modern Authentication of Pharmaceuticals Act of 2025, was introduced in the House on Feb 6, 2025 by Rep. Donald Davis (D) with 3 co-sponsors. It was referred to Energy And Commerce, and last saw action on Feb 6, 2025: Referred to the House Committee on Energy and Commerce.


Record

Text

H.R. 1060 has 3 co-sponsors.

hb1060/introduced-in-house.txt
119 HR 1060 IH: Modern Authentication of Pharmaceuticals Act of 2025
U.S. House of Representatives
2025-02-06
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 1st Session H. R. 1060 IN THE HOUSE OF REPRESENTATIVES February 6, 2025 Mr. Davis of North Carolina (for himself, Mr. Rutherford , and Mr. Bacon ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL
To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.
1.
Short title
This Act may be cited as the Modern Authentication of Pharmaceuticals Act of 2025 .
2.
Modernizing the authentication of controlled substances in the pharmaceutical distribution supply chain
(a)
In general
Section 582(a)(9) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360eee–1(a)(9) ) is amended—
(1)
in subparagraph (A)(ii), by striking and at the end;
(2)
by redesignating subparagraph (B) as subparagraph (C); and
(3)
by inserting after subparagraph (A) the following:
(B)
a physical chemical identifier shall be included in or on each dose of a product that is—
(i)
a controlled substance (as defined in section 102 of the Controlled Substances Act);
(ii)
in solid oral dosage form; and
(iii)
manufactured on or after the date that is five years after the date of enactment of the Modern Authentication of Pharmaceuticals Act of 2025 ; and
.
(b)
Conforming changes
(1)
Section 581(14) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360eee(14) ) is amended to read as follows:
(14)
Product identifier
The term product identifier means—
(A)
a standardized graphic that includes, in both human-readable form and on a machine-readable data carrier that conforms to the standards developed by a widely recognized international standards development organization, the standardized numerical identifier, lot number, and expiration date of the product; or
(B)
a physical chemical identifier, possessing a unique physical or chemical substance or combination of substances, that—
(i)
is in or on a product;
(ii)
is machine readable; and
(iii)
is intended to authenticate the product or a dosage form thereof.
.
(2)
Section 581(28) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360eee(28) ) is amended to read as follows:
(28)
Verification or verify
The term verification or verify means—
(A)
determining whether the product identifier affixed to, or imprinted upon, a package or homogeneous case corresponds to the standardized numerical identifier or lot number and expiration date assigned to the product by the manufacturer or the repackager, as applicable in accordance with section 582; or
(B)
determining whether a product or a dosage form thereof is authentic using a physical chemical identifier described in paragraph (14)(B).
.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-02-06
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Introduced in House Feb 6, 2025

hb1060/introduced-in-house.md

Shown Here:
Introduced in House (02/06/2025)

Modern Authentication of Pharmaceuticals Act of 2025

This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.

The bill applies to products manufactured beginning five years after the bill's enactment.

Sponsors

Rep. Donald Davis (D) sponsors H.R. 1060, and 3 members have co-sponsored it, 2 of them from the day it was introduced.

Committees

H.R. 1060 went before 1 committee: Energy and Commerce.

Energy and Commerce
Energy and Commerce
Referred To · Feb 6, 2025 · 1,636 Bills

Actions

H.R. 1060 has taken 3 actions since Feb 6, 2025.

ChamberAction
Feb 6, 2025
House
Introduced in House
Feb 6, 2025
House
Sponsor introductory remarks on measure. (CR H519)
Feb 6, 2025
House
Referred to the House Committee on Energy and Commerce.Energy and Commerce Committee

Votes

H.R. 1060 has not gone to a roll call.

Titles

H.R. 1060 goes by 3 titles, 1 of them short titles.

  • Modern Authentication of Pharmaceuticals Act of 2025 — Display Title
  • Modern Authentication of Pharmaceuticals Act of 2025 — Short Title(s) as Introduced
  • To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes. — Official Title as Introduced

Classification

The Congressional Research Service files H.R. 1060 under Health, one of its 31 policy areas, and gives it 4 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 1060’s is Health.

hr1060/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Legislative Subjects

H.R. 1060 carries 4 of CRS’s legislative subjects, from Drug safety, medical device, and laboratory regulation to Supply chain.

hr1060/subjects.txt
Drug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesPrescription drugsSupply chain

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 1060, as entered in the Congressional Record.

[Congressional Record Volume 171, Number 25 (Thursday, February 6, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. DAVIS of North Carolina:H.R. 1060.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 18.[Page H556]

Source: congress.gov · legiscan.com